ITCI
First Trust Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-663,916
| Closed | -$87.6M | – | 2725 |
|
|
2025
Q1 | $87.6M | Sell |
663,916
-102,218
| -13% | -$13.5M | 0.08% | 311 |
|
|
2024
Q4 | $64M | Buy |
766,134
+85,883
| +13% | +$7.17M | 0.06% | 427 |
|
|
2024
Q3 | $49.8M | Buy |
680,251
+96,659
| +17% | +$7.07M | 0.05% | 502 |
|
|
2024
Q2 | $40M | Sell |
583,592
-107,045
| -15% | -$7.33M | 0.04% | 560 |
|
|
2024
Q1 | $47.8M | Buy |
690,637
+679,811
| +6,279% | +$47M | 0.05% | 486 |
|
|
2023
Q4 | $775K | Sell |
10,826
-51,742
| -83% | -$3.71M | ﹤0.01% | 2041 |
|
|
2023
Q3 | $3.26M | Buy |
62,568
+40,649
| +185% | +$2.12M | ﹤0.01% | 1465 |
|
|
2023
Q2 | $1.39M | Sell |
21,919
-28,576
| -57% | -$1.81M | ﹤0.01% | 1871 |
|
|
2023
Q1 | $2.73M | Buy |
50,495
+18,997
| +60% | +$1.03M | ﹤0.01% | 1552 |
|
|
2022
Q4 | $1.67M | Sell |
31,498
-64,957
| -67% | -$3.44M | ﹤0.01% | 1777 |
|
|
2022
Q3 | $4.49M | Sell |
96,455
-11,427
| -11% | -$532K | 0.01% | 1243 |
|
|
2022
Q2 | $6.16M | Buy |
107,882
+10,273
| +11% | +$586K | 0.01% | 1130 |
|
|
2022
Q1 | $5.97M | Buy |
97,609
+38,786
| +66% | +$2.37M | 0.01% | 1233 |
|
|
2021
Q4 | $3.08M | Sell |
58,823
-51,282
| -47% | -$2.68M | ﹤0.01% | 1604 |
|
|
2021
Q3 | $4.11M | Buy |
110,105
+58,102
| +112% | +$2.17M | ﹤0.01% | 1443 |
|
|
2021
Q2 | $2.12M | Buy |
+52,003
| New | +$2.12M | ﹤0.01% | 1786 |
|
|
2019
Q1 | – | Sell |
-24,087
| Closed | -$274K | – | 2462 |
|
|
2018
Q4 | $274K | Buy |
+24,087
| New | +$274K | ﹤0.01% | 2281 |
|